| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |